Your browser doesn't support javascript.
loading
Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients.
Laracy, Justin C; Yan, Judy; Steiger, Samantha N; Tan, Carrie A; Cohen, Nina; Robilotti, Elizabeth V; Fender, Jerome; Cohen, Sara; Korde, Neha; Lee-Teh, Melissa; Noy, Ariela; Oved, Joseph H; Roeker, Lindsey E; Shah, Gunjan; Babady, N Esther; Kamboj, Mini; Seo, Susan K.
  • Laracy JC; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY. laracyj@mskcc.org.
  • Yan J; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Steiger SN; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Tan CA; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Cohen N; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Robilotti EV; Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Division of Infectious Diseases, Hospital for Special Surgery, New York, NY.
  • Fender J; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Digital Informatics and Technology Solutions, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Cohen S; Digital Informatics and Technology Solutions, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Korde N; Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Lee-Teh M; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Noy A; Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Oved JH; Department of Pediatric Transplant and Cell Therapy, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Roeker LE; Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Shah G; Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Babady NE; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kamboj M; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Seo SK; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY.
Haematologica ; 108(11): 3058-3067, 2023 11 01.
Article en En | MEDLINE | ID: mdl-37345467
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Profilaxis Pre-Exposición / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Profilaxis Pre-Exposición / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article